{"id":"W4385341021","doi":"10.1080/13696998.2023.2242197","title":"Cost-effectiveness analysis of cabozantinib compared with everolimus, axitinib, and nivolumab in subsequent line advanced renal cell carcinoma in Japan","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVRAZ (Canada)","funders":"Takeda Pharmaceutical Company","keywords":"Axitinib; Cabozantinib; Everolimus; Nivolumab; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Urology; Second line; Tyrosine-kinase inhibitor; Sunitinib; Immunotherapy; First line; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001748237,0.0002063876,0.001408941,0.001149762,0.00001831739,0.00001092836,0.0001634261,0.0001539343,0.00006317261],"category_scores_gemma":[0.0001572366,0.0001628822,0.0001912095,0.000850311,0.0001568592,0.00009997396,0.00006185032,0.0004854602,0.000002131135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004184414,"about_ca_system_score_gemma":0.0006140011,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002992681,"about_ca_topic_score_gemma":0.001097745,"domain_scores_codex":[0.9976777,0.0001569053,0.001111628,0.0002703357,0.0004412938,0.000342074],"domain_scores_gemma":[0.9981797,0.0004888364,0.0005536587,0.0002227865,0.0001269632,0.0004280664],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004942221,0.0006786462,0.9588321,0.0002747002,0.0006624478,0.001755833,0.0008101003,0.02440844,0.0008083244,0.00003326584,0.00002413049,0.006769775],"study_design_scores_gemma":[0.01630083,0.001528986,0.9519094,0.0003780338,0.0006217537,0.0002281093,0.0006690733,0.02437885,0.003714951,0.00001848092,0.0001103306,0.0001412346],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982787,0.0004409369,0.00003644805,0.0006194733,0.00007972916,0.0003959312,0.00001992738,0.000006462326,0.0001224141],"genre_scores_gemma":[0.998858,0.0006830212,0.0002298661,0.00007151546,0.00006096845,0.0000140705,0.00004302743,0.000022832,0.00001674856],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01135861,"threshold_uncertainty_score":0.6642143,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04274972990295816,"score_gpt":0.3051754524786486,"score_spread":0.2624257225756904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}